Next |
home / stock / bgne / bgne message board
Subject | By | Source | When |
---|---|---|---|
BGNE having a nice bounce and a good, | MiamiGent | investorshub | 07/05/2023 7:28:03 PM |
Thoughts on where this is headed? | StockLearner2011 | investorshub | 07/03/2023 9:49:33 PM |
Found an interesting article | luke424 | investorshub | 06/30/2023 1:45:08 AM |
$BGNE must see | StockLearner2011 | investorshub | 06/28/2023 1:49:55 AM |
here we go bulls news is here | StockLearner2011 | investorshub | 06/22/2023 3:12:55 PM |
Have a look at this | StockLearner2011 | investorshub | 06/22/2023 12:11:10 PM |
$BGNE MomentumIts trading | north40000 | investorshub | 06/21/2023 3:35:51 AM |
The trading last up | StockLearner2011 | investorshub | 06/20/2023 3:13:09 PM |
$BGNE short squeeze | luke424 | investorshub | 06/18/2023 5:16:26 AM |
MomentumIts now up | SweepsMcGee | investorshub | 06/14/2023 10:32:03 AM |
$BGNE where is the squeeze? | StockLearner2011 | investorshub | 06/12/2023 12:02:18 AM |
$BGNE should we be shorting? | StockLearner2011 | investorshub | 04/30/2023 7:59:54 PM |
$BGNE The trading | north40000 | investorshub | 04/29/2023 7:28:01 PM |
Long and strong lets hope im right | luke424 | investorshub | 04/27/2023 12:28:02 AM |
$BGNE short squeeze | MiamiGent | investorshub | 04/24/2023 3:35:51 PM |
Price gaining | StockLearner2011 | investorshub | 04/23/2023 2:43:18 PM |
Looks pretty positive | StockLearner2011 | investorshub | 04/17/2023 6:19:38 AM |
$BGNE MomentumIts now | StockLearner2011 | investorshub | 04/05/2023 2:19:08 AM |
$BGNE $271.915 +$6.91 (+2.609%) | MiamiGent | investorshub | 01/19/2023 2:49:53 PM |
BGNE presently $269.42 +$6.19 (+2.35%) | MiamiGent | investorshub | 01/13/2023 7:42:57 PM |
News, Short Squeeze, Breakout and More Instantly...
BeiGene Ltd. Company Name:
BGNE Stock Symbol:
NASDAQ Market:
Multiple presentations to showcase the efficacy and safety of BRUKINSA ® across a range of B-cell malignancies Company to present three-year data from RATIONALE-306 study of TEVIMBRA ® in advanced or metastatic esophageal squamous cell carcinoma (ESCC) Be...
U.S. stocks were higher, with the Nasdaq Composite gaining over 200 points on Tuesday. Shares of HealthStream, Inc. (NASDAQ:HSTM) rose sharply duri...
Comprehensive development program, including three Phase 3 clinical trials, demonstrated benefit of tislelizumab for patients with treatment-naïve and relapsed NSCLC Decision represents tislelizumab’s second approval in the region BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 0...